mjzanon – Page 148 – Protecting Your Trademarks & Patents in Brazil

GB Sciences files novel patent application for chronic pain treatments based on proprietary cannabis-derived formulations

Thursday, July 18, 2019 GB Sciences, Inc., through its subsidiary, GBS Global Biopharma, Inc., has filed a novel patent application

Compugen expands intellectual property portfolio for COM701 with new U.S. patent covering combination use with anti-PD-1 antibody

Tuesday, July 16, 2019 | DrugName : COM-701 Compugen Ltd., a clinical-stage cancer immunotherapy company and leader in predictive target

United States Patent and Trademark Office (USPTO) issues U.S. patent covering an enhanced formulation of Pliaglis

Tuesday, July 16, 2019 | DrugName : Pliaglis Crescita Therapeutics Inc., a commercial dermatology company with a portfolio of non-prescription

Spero Therapeutics announces $5.9 million award from U.S. Department of Defense to further clinical development of SPR206

Tuesday, July 16, 2019 | DrugName : SPR-206 Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing

Brazilian INPI’s New Program To Reduce The Patent Examination Backlog

On July 3, 2019, the Brazilian Ministry of Economy and the National Institute of Industrial Property (INPI) announced an urgent

Protecting Your Trademarks & Patents in Brazil